Sponsor Pipeline

Lyell Immunopharma, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
1
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07188558 A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy Large B-cell Lymphoma Recruiting
Phase 1/2
NCT05826535 Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma Relapsed Non-Hodgkin Lymphoma Recruiting
NCT05319314 LYL273 for Patients With Relapsed or Refractory mCRC Colorectal Cancer Recruiting
Disease Areas
Non-Hodgkin Lymphoma (2) Colorectal Cancer (1) DLBCL (1)
Get alerts when Lyell Immunopharma, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free